Jerome J. Dorlack
Known title: EVP, AmericasCIK: 0001697185
Associated companies
Transaction History
| ADNT | ▼ Sell | Tax Withholding | 5,896 | $156K | 2/8/2026 | View on chart |
| ADNT | ▲ Buy | Grant | 14,866 | $0 | 1/1/2026 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 5,234 | $100K | 1/1/2026 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 3,081 | $59K | 11/17/2025 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 3,506 | $70K | 11/16/2025 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 28,212 | $565K | 11/14/2025 | View on chart |
| ADNT | ▲ Buy | Grant | 7,559 | — | 11/13/2025 | View on chart |
| ADNT | ▲ Buy | Grant | 212,765 | — | 11/13/2025 | View on chart |
| ADNT | ▼ Sell | Open Market | 12,000 | $273K | 8/7/2025 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 6,262 | $106K | 2/8/2025 | View on chart |
| ADNT | ▲ Buy | Grant | 16,540 | — | 1/1/2025 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,658 | $46K | 1/1/2025 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,193 | $43K | 11/18/2024 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,990 | $59K | 11/17/2024 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 3,506 | $70K | 11/16/2024 | View on chart |
| ADNT | ▲ Buy | Grant | 196,078 | — | 11/14/2024 | View on chart |
| ADNT | ▲ Buy | Grant | 11,979 | — | 11/14/2024 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 5,014 | $102K | 11/14/2024 | View on chart |
| ADNT | ▲ Buy | Grant | 62,462 | — | 2/8/2024 | View on chart |
| ADNT | ▲ Buy | Grant | 7,838 | $0 | 1/1/2024 | View on chart |
| ADNT | ▼ Sell | Open Market | 17,884 | $633K | 12/15/2023 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 808 | $27K | 12/1/2023 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 3,302 | $108K | 11/19/2023 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,129 | $70K | 11/18/2023 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,990 | $98K | 11/17/2023 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 24,561 | $806K | 11/16/2023 | View on chart |
| ADNT | ▲ Buy | Grant | 66,810 | — | 11/16/2023 | View on chart |
| ADNT | ▲ Buy | Grant | 24,367 | — | 11/16/2023 | View on chart |
| ADNT | ▲ Buy | Grant | 1,852 | $0 | 12/1/2022 | View on chart |
| ADNT | ▼ Sell | Open Market | 4,300 | $168K | 11/23/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 3,205 | $127K | 11/19/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 16,285 | $644K | 11/18/2022 | View on chart |
| ADNT | ▲ Buy | Grant | 47,365 | $0 | 11/17/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 17,245 | $664K | 11/17/2022 | View on chart |
| ADNT | ▲ Buy | Grant | 20,779 | $0 | 11/17/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 1,197 | $36K | 7/1/2022 | View on chart |
| ADNT | ▼ Sell | Open Market | 7,600 | $238K | 5/10/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 3,205 | $148K | 11/19/2021 | View on chart |
| ADNT | ▲ Buy | Grant | 14,789 | $0 | 11/18/2021 | View on chart |
| ADNT | ▲ Buy | Grant | 22,498 | $0 | 11/18/2021 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 23,235 | $1.1M | 11/18/2021 | View on chart |
| ADNT | ▼ Sell | Open Market | 7,800 | $366K | 11/12/2021 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,131 | $89K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Adient Q4 Earnings Set for Nov. 4 as Analysts Trim Targets
Adient will report fourth-quarter and full-year fiscal 2026 results on November 4, 2026. Ahead of this announcement, Barclays and UBS both lowered their price targets to $22 and $23, respectively, while maintaining their ratings. Recent commentary also highlights strong backlog growth driven by onshoring initiatives and new customer wins.
Adient Q4 Earnings Set for Nov. 4 as Analysts Trim Targets. Adient will report fourth-quarter and full-year fiscal 2026 results on November 4, 2026. Ahead of this announcement, Barclays and UBS both lowered their price targets to $22 and $23, respectively, while maintaining their ratings. Recent commentary also highlights strong backlog growth driven by onshoring initiatives and new customer wins.